Yang Su

Associate Director, Oncology


Wuxi, China


Ph.D. in Biophysics, Fudan University

Previous Experience:

I have more than 14 years of experience in novel therapeutic target and antibody-based drug discovery against cancer, serving as a strong driver to accelerate cytotoxic, immunomodulatory, and degrader ADC projects to the advanced stages at UCSF, Remegen Bioscience, and BMS.

Responsibilities at insitro:

Reporting to the oncology discovery therapeutic head, I will work with data science and machine learning, translational oncology and computational biology colleagues to gain deep insights into the biology and efficacy of antibody drug conjugates (ADCs) with the goal of delivering therapeutics to the right patients.